Program monitoring for clinical practice. Specimen positivity across urine collection methods.
Urinalysis is a primary component of methadone programming. A clinic-based study was conducted to determine whether unsupervised urine collection is as reliable as other methods for detecting unauthorized drug use among methadone treatment clients. Drug positivity rates compared over a 30-week period revealed no significant differences as a function of collection method. Results confirm the efficacy of unsupervised urine collection using a heat sensitive strip or temperature indicator. Study findings also offer evidence to support clinical practice designed to ensure client privacy and dignity while maintaining standards for effective program monitoring.
D000328:Adult; D005260:Female; D006801:Humans; D013287:Illicit Drugs / Q000493:pharmacokinetics; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D008875:Middle Aged; D009293:Opioid-Related Disorders / Q000175:diagnosis* / Q000534:rehabilitation / Q000652:urine; D011619:Psychotropic Drugs / Q000493:pharmacokinetics; D015203:Reproducibility of Results; D013048:Specimen Handling; D015813:Substance Abuse Detection; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000534:rehabilitation / Q000652:urine; D016896:Treatment Outcome
D013287:Illicit Drugs; D011619:Psychotropic Drugs; D008691:Methadone